Mark Namchuk

Mark Namchuk, PhD, is the Puja and Samir Kaul Professor of the Practice of Biomedical Innovation and Translation and Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School (HMS). As Executive Director of Therapeutics Translation, he bridges basic research and clinical therapies, advancing scientific discoveries along translational trajectories while training future therapeutics investigators.

• Former Senior Vice President of Research and Nonclinical Development at Alkermes
• Leadership roles in drug discovery at Vertex Pharmaceuticals and Cubist Pharmaceuticals
• Expertise in therapeutic areas: oncology, neurodegenerative disorders, infectious diseases

His research focuses on integrating translational science with pharmaceutical development, emphasizing biomarker development and nonclinical safety. He holds degrees from the University of Alberta (BSc) and University of British Columbia (PhD), with postdoctoral training at the University of California, San Francisco.